Abstract: A process for obtaining oils of sesquiterpenes and sesquilactones and (?)-guaiol from the oil of Callitris intratropica, processes for encapsulation of the oil from Callitris intratropica, and the various uses of the oil and the encapsulated oil are described. The oils are suitable for various purposes in the personal care field, e.g. for the antimicrobial treatment of skin, mucosa and hair and of textile fibre materials, as an antimycotic against skin fungi and moulds, as an anti-inflammatory, as an acaricide against house dust mites and ticks, and for preserving cosmetic products.

Abstract: The present invention relates to the use as a perfuming ingredient of 2-methyl-3-hexanone-oxime of formula in which the wavy line represents a bond having a configuration of the type (Z) or (E) or a mixture of the two configurations.

Abstract: The present invention relates to the perfumery industry. It concerns more particularly an alcohol, ester, ether or ketone derivative having a spiro-type skeleton, the latter being substituted by short alkyl groups. The invention also relates to the use of the invention compounds as perfuming ingredients, able to impart a woody and/or aromatic, as well as to the perfumed articles or perfuming compositions comprising as active ingredient a compound of formula (I).

Abstract: A process for obtaining oils of sesquiterpenes and sesquilactones and (−)-guaiol from the oil of Callitris intratropica, processes for encapsulation of the oil from Callitris intratropica, and the various uses of the oil and the encapsulated oil are described. The oils are suitable for various purposes in the personal care field, e.g. for the antimicrobial treatment of skin, mucosa and hair and of textile fibre materials, as an antimycotic against skin fungi and moulds, as an anti-inflammatory, as an acaricide against house dust mites and ticks, and for preserving cosmetic products.

Abstract: The present invention relates to the use as a perfuming ingredient of 2-methyl-3-hexanone-oxime of formula 1

Abstract: A description is given of the use of polyanionic and polyanionically-derivatised natural polysaccharides or non-derivatised natural polysaccharides for inhibiting alkaline phosphatase and of oral compositions for preventing bacterial plaque, which comprises (a) 0 to 10% by weight of at least one linear molecularly dehydrated polyphosphate salt, and (b) 0.0001 to 5% by weight of a polyanionic or polyanionically-derivatised natural polysaccharide.

Abstract: The invention describes the use of micronized organic UV filters for preventing tanning and for lightening human skin and hair, and their use in cosmetic and pharmaceutical formulations. The micronized UV filters used according to the invention cover a broad UV spectrum and therefore have excellent sunscreen properties.

Abstract: The invention describes the use of micronized organic UV filters for preventing tanning and for lightening human skin and hair, and their use in cosmetic and pharmaceutical formulations.

Abstract: 4-Methyl-4-(4-mlthylpent-3-en-1-yl)-2-oxetanone of formula (1): or its oligomer is an intermediate product for the preparation of a series of geranic acid derivatives, which are important synthetic building blocks in the preparation of perfumes and fragrances.

Abstract: The present invention provides a microstructured cosmetic composition comprising:A) a cosmetically acceptable oil phase which is dispersed in;B) an aqueous phase comprising 0.05 to 3.0, preferably 0.2 to 1.0% by weight, based on the weight of the total composition, of a .beta.-1,3-glucan having a mean molecular weight within the range of from 1.times.10.sup.6 to 12.times.10.sup.6, preferably from 2.times.10.sup.6 to 10.times.10.sup.6 ;the oil phase A) in the microstructured cosmetic composition having a mean particle size within the range of from 0.05 to 1000 microns.

Abstract: The present invention relates to a method for the improvement of the sun protection factor (SPF) of textile fiber material, comprising applying to the textile fiber material a detergent comprising at least one fluorescent whitening agent, which absorbs radiation in the wavelength range 280-400 nm, preferably by washing the textile fiber material with a detergent containing said fluorescent whitening agent.

Abstract: A cosmetic composition is provided comprising:A) a cosmetically acceptable carrier; andB) 0.05 to 3.0% by weight, based on the weight of the total composition, of a .beta.-1,3-glucan having a mean molecular weight of 10.sup.5 to 25.10.sup.6.

Abstract: The compounds of formula ##STR1## wherein the Z group can be located in positions ortho-, meta- or para-relative to the carboxylic group, symbol R.sup.1 stands for a saturated or unsaturated, linear or branched C.sub.1 to C.sub.4 alkyl radical anda. the dotted lines represent a cyclohexanic moiety and Z represents a ##STR2## group, R.sup.2 being a saturated or unsaturated, linear or branched C.sub.1 to C.sub.4 alkyl radical; orb. the dotted lines represent a cyclohexanic or benzenic moiety and Z represents a group of formula ##STR3## in which R.sup.2 is a saturated or unsaturated, linear or branched C.sub.1 to C.sub.4 alkyl radical, are useful as perfuming ingredients for the preparation of perfuming compositions and a variety of perfumed consumer articles. They impart to the latter odor notes of the fruity and floral type.

Abstract: (1RS,5RS)-5-Methyl-exo-tricyclo[6.2.1.0.sup.2,7 ]undecan-4-one, as well as the compositions which contain a preponderant amount of this compound together with its isomer (1RS,5SR)-5-methyl-exo-tricyclo[6.2.1.0.sup.2,7 ]undecan-4-one, are useful as perfuming ingredients for the preparation of perfuming compositions and perfumed articles, to which they impart aromatic, thujonic and herbaceous odors.

Abstract: Perfuming composition or perfumed article containing as a perfuming ingredient at least one pentadecenolide of formula ##STR1## having a double bond of trans configuration in one of the positions 11 or 12 such as indicated by the dotted lines. Compounds (I) develop musky, animal odor notes, reminiscent of natural musk.

Abstract: A process for the preparation of 15-pentadecanolide, wherein bis-(13-oxabicyclo[10.4.0]hexadec-12-yl)peroxide is subjected to a thermal treatment in an organic solvent, eventually followed by hydrogenation of the resulting reaction product, which treatment is carried out in an organic solvent having a boiling point comprised between about 170.degree. and 250.degree. C.

Abstract: The present invention relates to a transdermal therapeutic system for the combined administration of oestrogens and gestagens. The therapeutic system consists of:(1) a closed outer layer which is impermeable to the constituents of the active ingredient formulation,(2) a reservoir containing essential constituents of the active ingredient formulation and, optionally, a membrane,(3) an adhesive layer and(4) a peel-off protective layer on the adhesive layer.The system contains an oestrogen derivative in combination with a synthetic gestagen, and an agent that enhances percutaneous absorption.

Abstract: The invention relates to a monolith transdermal therapeutic system for the delivery of permeable drugs, especially formoterol, in the form of a matrix system comprising three layers: a) a backing layer which is impermeable to the components of the adhesive layer b),b) an adhesive layer capable of releasing the drug and consisting of a permeable polymeric material which is compatible with the skin and contains at least one drug which is capable of permeation across the skin, a combination of eucalyptol having a purity of at least 70% with an additional flux enhancer and further optional pharmaceutical excipients, andc) a protective release liner which can be peeled from the adhesive contact layer b).

Abstract: There are disclosed novel pharmaceutical compositions which comprise diclofenac or a salt thereof, a penetration agent such as 1-n-dodecylazacycloheptan-2-one or dimethyllauroylamide and, as vehicle, a mineral oil. These compositions have excellent skin penetration properties and can therefore be used in transdermal therapeutic systems (TTS) as drug reservoir.

Abstract: The invention relates to pharmaceutical compositions containing synthetic, substantially pure phosphatidyl serine and phosphatidyl choline and a substance or a mixture of substances having biological activity. The invention also relates to mixtures comprising synthetic, substantially pure phosphatidyl serine and phosphatidyl choline, and also to processes for the manufacture of the pharmaecutical compositions, and the use thereof.